Research

The Masonic Cancer Center, University of Minnesota is hosting its 7thAnnual Cancer Research Symposium today and tomorrow, Nov. 2-3, at TCF Bank Stadium.
With the goal of celebrating 25 years of research innovation, discovery, and collaborations, the 2-day event will feature internationally recognized cancer researchers and doctors, many of who currently work or have trained at the Masonic Cancer Center, as well as current trainee presenters that represent the vision of tomorrow.

University of Minnesota researcher, Dr. Carol Lange and team are one of two grand prize winners in the National Cancer Institute’s Up for A Challenge (U4C) Breast Cancer Challenge Award offered in partnership with Sage Bionetworks. The recognition will help further the University’s innovative work in exploring genetic connections in breast cancer research.  

Good news for children age 14 and under: the human papillomavirus (HPV) vaccine now only requires two shots. 

Sixty-one percent of early childcare providers in Minnesota are serving a fruit or vegetable at every meal and snack. That’s according to a new University of Minnesota survey of licensed center- and home-based early childcare providers.

People who are overweight have a 25 percent higher chance of developing a depressive illness, while people who are obese have a 50 percent higher chance.

Kola Okuyemi, MD, MPH, director of the Program in Health Disparities Research and professor in the Department of Family Medicine and Community Health, recently received a $1.5 million renewal grant to educate researchers to reduce cancer-related health disparities among underserved populations.  

A recent study in the New England Journal of Medicine revealed potential benefits of ZMapp, an experimental immune-based treatment for Ebola studied within the PREVAIL II trial.

New grants through President Obama’s BRAIN Initiative will allow University of Minnesota researchers to dive deeper into the brain, developing new imaging technology with the potential to map and study neural activity to much greater detail.

University of Minnesota Medical School researchers identified a potential target for treating Alzheimer’s disease, which reversed memory loss in mice. The study could translate into new treatments and provides insight into what may be causing the disease.
 

Researchers have discovered that a protein found naturally in cells that provide some protection from viruses is responsible for creating mutations that drive resistance to tamoxifen treatment in breast cancer. Because the protein, known as APOBEC3B, is found in elevated quantities in other kinds of cancer cells, the finding explains differential responses to treatment and opens the door to boosting the effectiveness of tamoxifen and related breast cancer therapies that inhibit the ability of estrogen to stimulate tumor growth. 

Pages